• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Investigation of effects of angiotensin type 2 receptors on extracellular matrix synthesis for renal therapy

Research Project

Project/Area Number 12671047
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Kidney internal medicine
Research InstitutionKeio University

Principal Investigator

SASAMURA Hiroyuki  School of Medicine, Keio University, Associate, 医学部, 助手 (00235293)

Co-Investigator(Kenkyū-buntansha) HAYASHI Matsuhiko  School of Medicine, Keio University, Associate Professor, 医学部, 助教授 (60129608)
Project Period (FY) 2000 – 2001
Project Status Completed (Fiscal Year 2001)
Budget Amount *help
¥1,600,000 (Direct Cost: ¥1,600,000)
Fiscal Year 2001: ¥700,000 (Direct Cost: ¥700,000)
Fiscal Year 2000: ¥900,000 (Direct Cost: ¥900,000)
KeywordsAngiotensin / Receptor / Extracellular Matrix
Research Abstract

In this study, we examined the effects of angiotensin II type 1 (ATI) and type 2 (AT2) receptor stimulation on synthesis of extracellular matrix proteins, including collagen and proteoglycans using a vascular smooth muscle cell line (VSMG-AT2) expressing AT2 receptors. Stimulation of these cells with the AT2 receptor agonist CGP42112A did not cause a significant change in ERK1/2 activity but caused a small but significant decrease in protein tyrosine phosphatase activity. The stimulation of the AT2 receptor also caused a dose- and time-dependent increase in both cell-associated and secreted collagen synthesis to 148+17% of control levels (p<0.05), The effects of AT1 and AT2 receptor stimulation on proteoglycan synthesis were next examined. Stimulation of the AT1 receptor caused a dose- and time-dependent increase in proteoglycan synthesis. DEAE-Sephacel chromatography revealed an increase in both HSPG and CS/DSPG, while Northern blot analysis showed' that biglycan, versican, and perlecan mRNA were increased, Stimulation of the AT2 receptor alone also caused a small but significant increase in proteoglycan synthesis which was unaffected by tyrosine kinase and MEK inhibitors but attenuated by pertussis toxin. In vivo studies using angiotensin receptor blocker (ARB) showed that ARB treatment caused a decrase in biglycan and decorin mRNA but an increase in versican mRNA. These results suggested that angiotensin II can regulate extracellular matrix synthesis by both AT1 and AT2 receptors through multiple mechanisms.

Report

(3 results)
  • 2001 Annual Research Report   Final Research Report Summary
  • 2000 Annual Research Report
  • Research Products

    (16 results)

All Other

All Publications (16 results)

  • [Publications] Mifune., et al.: "Angiotensin II Type 2 receptors stimulate collagen synthesis in cultured vascular smooth muscle cells"Hypertension. 36. 845-850 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Sasamura., et al.: "Effects of AT1 receptor antagonist on proteoglycan gene expression in hypertensive rats"Hypertension Research. 24. 165-172 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Nakaya., et al.: "Temporary treatment of prepubesant rats with angiotensin inhibitoes suppresses the development of hypentensive nephrosclerosis"Journal of the American Society of Nephrology. 12. 659-666 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Mifune., et al.: "Examination of angiotensin II type 1 and type 2 receptor exprossion in human kidneys by immunohertocle Minitry"Clinnal and Expermental Hypertension. 23. 257-266 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Shinizu-Hirota., et al.: "Regulation of vascular proteoglycan synthesis by angiotensin II type 1 and type 2 receptors"Journal of the American Society of Nephrology. 12. 2609-2615 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] M. Mifune, H. Sasamura, R. Shimizu-Hirota, H. Miyazaki, T. Saruta: "Angiotensin II type 2 receptors stimulate collagen synthesis in cultured vascular smooth muscle cells"Hypertension. 36. 845-850 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] H. Sasamura, M. Mifune, H. Nakaya, T. Amemiya, T. Hiraki, I. Nishimoto, T. Saruta: "Analysis of Galpha protein recognition profiles of angiotensin II receptors using chimeric Galpha proteins"Molecular and Cellular Endocrinology. 170. 113-121 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] H. Sasamura, R. Shimizu-Hirota, H. Nakaya, T. Saruta: "Effects of AT1 receptor antagonist on proteoglycan gene expression in hypertensive rats"Hypertension Research. 24. 165-172 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] H. Nakaya, H. Sasamura, M. Hayashi, T. Saruta: "Temporary treatment of prepubescent rats with angiotensin inhibitors suppresses the development of hypertensive nephrosclerosis"Journal of the American Society of Nephrology. 12. 659-666 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] M. Mifune, H. Sasamura, Y. Nakazato, Y. Yamaji, N. Oshima, T. Saruta: "Examination of angiotensin II type 1 and type 2 receptor expression in human kidneys by immunohistochemistry"Clinical and Experimental Hypertension. 23. 257-266 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] R. Shimizu-Hirota, H. Sasamura, M. Mifune, H. Nakaya, M. Kuroda, M. Hayashi, T. Saruta: "Regulation of vascular proteoglycan synthesis by angiotensin II type 1 and type 2 receptors"Journal of the American Society of Nephrology. 12. 2609-2615 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Sasamura et al.: "Effects of AT1 receptor antagonist on proteoglycan gene expression in hypertensive rats"Hypertension Research. 24(3). 165-172 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Nakaya et al.: "Temporary treatment of piepubescent rats with angiotensin inhibitors suppresses the development of hypertersive nephrosderasis"Journal of the American Society of Nephrology. 12(4). 659-666 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Mifune et al.: "Examination of angiotensin II type 1 and type 2 receptor expression in human kidneys by immunohistochemistry"Clinical and Experimental Hypertension. 23(4). 257-266 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Shimizu-Hirota et al.: "Regulation of vascular proteoglycan synthesis by angiotensin II type 1 and type 2 receptors"Journal of the American Society of Nephrology. 12(12). 2609-2615 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Mifune et al: "Angiotensin II type 2 receptors stimulate couagen synthesis in cultured vascular smooth muscle cells"Hypertension. 36. 845-850 (2000)

    • Related Report
      2000 Annual Research Report

URL: 

Published: 2000-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi